SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 15th, 2020 • Aikido Pharma Inc. • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 14, 2020, between AIkido Pharma Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT AIkido Pharma Inc.Placement Agent Common Stock Agreement • April 15th, 2020 • Aikido Pharma Inc. • Services-commercial physical & biological research
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 14, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from AIkido Pharma Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, date as of January 24, 2020, as amended, by and between the Company and H.C. Wainwright & Co., LLC.
